Investment Rating - The report assigns an "Accumulate" investment rating for the company, with a current stock price of 75.5 HKD [2]. Core Insights - The company, UBTECH, is a leading player in the humanoid robot sector in China, focusing on the commercialization of its products. It is expected to enter small-scale production and delivery this year, aiming for early commercialization [1][6]. - Revenue has shown consistent growth, with a compound annual growth rate (CAGR) of 15.0% from 2020 to 2024, driven primarily by consumer-grade and intelligent logistics robots. However, the company faces short-term profitability pressure due to high R&D and market expansion costs [6][22]. - The company has a comprehensive technology layout in humanoid robots, with six models currently available, including the Walker S series for industrial applications and others for commercial and household services. The industrial sector is a key focus for future applications [6][37]. Summary by Sections Company Overview - UBTECH is the first publicly listed company in China focused on humanoid robots, with products catering to family, commercial, and industrial applications. The company has expanded its product matrix since its establishment in 2012 [11][12]. Financial Performance - Revenue increased from 740 million CNY in 2020 to 1.295 billion CNY in 2024, with a net loss narrowing from 1.234 billion CNY in 2023 to 1.124 billion CNY in 2024. The net profit margin improved from -120.8% to -88.9% due to cost control measures [6][22][28]. Product and Technology Development - The company has developed a full range of humanoid robots, with a focus on the Walker S series for industrial applications. The robots are equipped with advanced perception, control, and execution systems, enhancing their operational capabilities in various environments [6][37][49]. - UBTECH's R&D investment has consistently exceeded 35% of revenue, supporting technological breakthroughs in humanoid robotics. The company holds 2,680 authorized patents, with over 480 overseas patents [29][33]. Market Outlook - The report forecasts revenue growth for the company, estimating revenues of 1.891 billion CNY, 2.662 billion CNY, and 3.621 billion CNY for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 45%, 41%, and 36% [6][7][22].
优必选（09880）：国产人形机器人领军者，持续推进商业化进程